A detailed history of Rock Point Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Rock Point Advisors, LLC holds 91,410 shares of PFE stock, worth $2.66 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares
91,410
Previous 92,253 0.91%
Holding current value
$2.66 Million
Previous $2.56 Million 0.12%
% of portfolio
0.78%
Previous 0.77%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$25.26 - $29.6 $21,294 - $24,952
-843 Reduced 0.91%
91,410 $2.56 Million
Q1 2024

May 10, 2024

BUY
$25.89 - $29.73 $325,566 - $373,854
12,575 Added 15.78%
92,253 $2.56 Million
Q4 2023

Feb 08, 2024

SELL
$26.13 - $33.94 $136,842 - $177,743
-5,237 Reduced 6.17%
79,678 $2.29 Million
Q3 2023

Nov 09, 2023

BUY
$32.09 - $37.51 $238,974 - $279,336
7,447 Added 9.61%
84,915 $2.82 Million
Q2 2023

Aug 10, 2023

BUY
$36.12 - $41.79 $76,213 - $88,176
2,110 Added 2.8%
77,468 $2.84 Million
Q1 2023

May 10, 2023

BUY
$39.39 - $51.28 $171,661 - $223,478
4,358 Added 6.14%
75,358 $3.08 Million
Q4 2022

Feb 09, 2023

SELL
$41.75 - $54.5 $51,686 - $67,471
-1,238 Reduced 1.71%
71,000 $3.64 Million
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $27,962 - $34,135
-639 Reduced 0.88%
72,238 $3.16 Million
Q2 2022

Aug 10, 2022

SELL
$46.53 - $55.17 $476,094 - $564,499
-10,232 Reduced 12.31%
72,877 $3.82 Million
Q1 2022

May 10, 2022

SELL
$45.75 - $56.69 $316,498 - $392,181
-6,918 Reduced 7.68%
83,109 $4.3 Million
Q4 2021

Feb 09, 2022

SELL
$41.32 - $61.25 $78,921 - $116,987
-1,910 Reduced 2.08%
90,027 $5.32 Million
Q3 2021

Nov 05, 2021

SELL
$39.25 - $50.42 $181,374 - $232,990
-4,621 Reduced 4.79%
91,937 $3.95 Million
Q2 2021

Aug 05, 2021

SELL
$35.91 - $40.68 $241,243 - $273,288
-6,718 Reduced 6.5%
96,558 $3.78 Million
Q1 2021

May 12, 2021

BUY
$33.49 - $37.77 $675,560 - $761,896
20,172 Added 24.27%
103,276 $3.74 Million
Q4 2020

Feb 08, 2021

BUY
$33.47 - $42.56 $2.33 Million - $2.96 Million
69,500 Added 510.88%
83,104 $3.06 Million
Q3 2020

Nov 10, 2020

SELL
$31.75 - $37.25 $84,613 - $99,271
-2,665 Reduced 16.38%
13,604 $499,000
Q2 2020

Aug 12, 2020

SELL
$30.12 - $36.54 $10,542 - $12,789
-350 Reduced 2.11%
16,269 $532,000
Q4 2019

Feb 06, 2020

SELL
$32.92 - $37.36 $823 - $934
-25 Reduced 0.15%
16,619 $651,000
Q3 2019

Nov 08, 2019

BUY
$32.49 - $42.13 $5,133 - $6,656
158 Added 0.96%
16,644 $598,000
Q2 2019

Aug 12, 2019

SELL
$36.98 - $41.52 $21,448 - $24,081
-580 Reduced 3.4%
16,486 $714,000
Q1 2019

May 08, 2019

SELL
$37.5 - $41.2 $75,000 - $82,400
-2,000 Reduced 10.49%
17,066 $725,000
Q4 2018

Jan 31, 2019

SELL
$38.47 - $43.86 $3,847 - $4,386
-100 Reduced 0.52%
19,066 $832,000
Q3 2018

Nov 07, 2018

SELL
$34.47 - $41.81 $54,290 - $65,850
-1,575 Reduced 7.59%
19,166 $845,000
Q2 2018

Aug 09, 2018

BUY
$32.98 - $35.16 $8,080 - $8,614
245 Added 1.2%
20,741 $752,000
Q1 2018

May 11, 2018

SELL
$31.91 - $37.02 $10,849 - $12,586
-340 Reduced 1.63%
20,496 $727,000
Q4 2017

Feb 09, 2018

SELL
$33.26 - $35.29 $23,049 - $24,455
-693 Reduced 3.22%
20,836 $755,000
Q3 2017

Nov 03, 2017

BUY
$31.0 - $34.15 $667,399 - $735,215
21,529
21,529 $769,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $163B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Rock Point Advisors, LLC Portfolio

Follow Rock Point Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Point Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rock Point Advisors, LLC with notifications on news.